Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,066 public trials 1,184 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, not recruiting

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

NCT03414970

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 859 locations
View Trial Details
Active, not recruiting

177LuPSMA in Renal Cell Carcinoma

NCT06964958

Conditions
Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +16 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

NCT04430738

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
View all 27 locations
View Trial Details
Active, not recruiting

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

NCT04471727

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +26 more
Locations
  • Cedar-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

NCT02811861

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Stanford School of Medicine Stanford, California, United States
  • Boca Raton Community Hospital Boca Raton, Florida, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • University of Miami Miami, Florida, United States
View all 183 locations
View Trial Details
Active, not recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details
Active, not recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details

Related conditions